3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
235
Lymphoma
160
Leukemia
109
Burkitt Lymphoma
91
Lymphoma, Non-Hodgkin
85
Lymphoma, Large B-Cell, Diffuse
80
Lymphoma, Mantle-Cell
70
Leukemia, Myeloid, Acute
53
Lymphoma, Follicular
49
Hodgkin Disease
44
Lymphoma, Large-Cell, Immunoblastic
37
Leukemia, Lymphocytic, Chronic, B-Cell
33
Recurrence
32
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma, B-Cell, Marginal Zone
24
Leukemia, Biphenotypic, Acute
24
Myelodysplastic Syndromes
23
Blast Crisis
19
Lymphoma, Large-Cell, Anaplastic
18
Lymphoma, B-Cell
18
Dendritic Cell Sarcoma, Interdigitating
17
Congenital Abnormalities
17
Leukemia, Myeloid, Accelerated Phase
16
Leukemia, Myelomonocytic, Chronic
15
Multiple Myeloma
12
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, T-Cell
11
Myeloproliferative Disorders
10
Anemia, Refractory, with Excess of Blasts
10
Neoplasms, Plasma Cell
9
Interventions
Cyclophosphamide
13
fludarabine
9
fludarabine phosphate
7
Bendamustine Hydrochloride
5
Rituximab
4
Busulfan
4
ibrutinib
3
Tacrolimus
3
Mycophenolic Acid
3
Melphalan
3
Bortezomib
3
AP 1903 reagent
3
tetulomab tetraxetan lu-177
2
ponatinib
2
cobomarsen
2
Whole-Body Irradiation
2
Vorinostat
2
Vincristine
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mesna
2
Lutetium
2
Etoposide
2
Doxorubicin
2
Brentuximab Vedotin
2
Bone Marrow Transplantation
2
pembrolizumab
1
ibritumomab tiuxetan
1
enzalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Immune System Diseases
×
Cytarabine
×
Lymphoid
×
Clear all
NCT02366663
2018-03-12
SPINOZA
City of Hope Medical Center
Phase 3
Terminated
3 enrolled
8 charts